KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ClearPoint Neuro (CLPT) Other Working Capital Changes (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Other Working Capital Changes for 13 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 99.41% to -$1.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$319000.0 through Dec 2025, up 46.57% year-over-year, with the annual reading at -$319000.0 for FY2025, 46.57% up from the prior year.
  • Other Working Capital Changes hit -$1.0 million in Q4 2025 for ClearPoint Neuro, down from $696000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.1 million in Q2 2022 to a low of -$1.0 million in Q4 2025.
  • Historically, Other Working Capital Changes has averaged -$60555.6 across 5 years, with a median of -$111000.0 in 2021.
  • Biggest YoY gain for Other Working Capital Changes was 2470.83% in 2022; the steepest drop was 853.04% in 2022.
  • Year by year, Other Working Capital Changes stood at $93000.0 in 2021, then surged by 298.92% to $371000.0 in 2022, then crashed by 238.54% to -$514000.0 in 2023, then increased by 0.97% to -$509000.0 in 2024, then plummeted by 99.41% to -$1.0 million in 2025.
  • Business Quant data shows Other Working Capital Changes for CLPT at -$1.0 million in Q4 2025, $696000.0 in Q3 2025, and -$509000.0 in Q4 2024.